Category: Hiring

2031 DNA Sequencing Market Forecast: Size, Share, and Future Growth | by Harsha Dalal | Dec, 2023

The 2024 research report on the “DNA Sequencing Market” provides an in-depth and comprehensive analysis of industry segmentation, which is based on Types [Semiconductor Sequencing, Pyrosequencing, Sequencing by Synthesis, Single-Molecule Real-Time Sequencing (SMRT), Sequencing by Ligation (SBL), Others], Applications [Diagnostic, Drug Discovery, Biomarker Discovery, Personalized Medicine, Others], and Regions. This…

Continue Reading 2031 DNA Sequencing Market Forecast: Size, Share, and Future Growth | by Harsha Dalal | Dec, 2023

python – SLURM: Run Same Parallel Script on Multiple Files

First, you need to be careful with your usage of –ntasks-per-node. The directives for sbatch can be a little bit confusing at first: –nodes — this is the number of nodes that you are requesting for your job. Note: the number of CPUs per node entirely depends on the cluster…

Continue Reading python – SLURM: Run Same Parallel Script on Multiple Files

Global DNA Sequencing Equipment Market Trend And Analysis

DNA Sequencing Equipment Market Size And Overview The competitive landscape, market drivers and challenges, and current market trends are all thoroughly examined in our report on the global DNA Sequencing Equipment Market. In addition to offering a realistic assessment of the market’s size and future growth potential, this report offers…

Continue Reading Global DNA Sequencing Equipment Market Trend And Analysis

Preprint peer review gains momentum with new

4 December 2023 – Review Commons, a platform dedicated to the peer review of preprints, announces the expansion of its family of affiliate journals to include publications from three additional organizations. Affiliate journals accept the transfer of peer-reviewed preprints directly from the Review Commons online portal into their editorial workflow, where they are assessed…

Continue Reading Preprint peer review gains momentum with new

New member, Mtdna H63…from Italy

Greetings all. I am brandy new to this forum and new to genetic testing in general. I recently completed both an autosomal DNA test on FTDNA and a full Mtdna, also on FTDNA. While I have traced my father’s family back to the late 17th century in Italy, I cannot…

Continue Reading New member, Mtdna H63…from Italy

Animal Microbiome Market Latest Updated Report 2023-2031

PRESS RELEASE Published December 5, 2023 Animal Microbiome Market Assessment worth $ 12.4 Billion by 2030 – Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Animal Microbiome Market– by Products (Phage Therapy Product, Functional Food (Probiotics, Prebiotics and…

Continue Reading Animal Microbiome Market Latest Updated Report 2023-2031

– The Great Awakening – Where We Go Qne, We Go All!

Q Supporters:This is The Great Awakening. Our community is international, focused on helping ourselves and others walk away from the programming, and return our governments to “by the people, for the people!” Follow the Law:No posts or comments that violate laws in your jurisdiction or the United States. The Feds…

Continue Reading – The Great Awakening – Where We Go Qne, We Go All!

AI-Powered Protein Structure Prediction: AlphaFold 2 Unlocks a World of Possibilities

In a remarkable breakthrough, a new artificial intelligence (AI) algorithm has demonstrated an unprecedented ability to predict the three-dimensional structures of proteins with high accuracy. This groundbreaking achievement, published in the journal Nature, marks a significant step forward in the field of bioinformatics and holds immense promise for advancing our…

Continue Reading AI-Powered Protein Structure Prediction: AlphaFold 2 Unlocks a World of Possibilities

EMBO announces new Young Investigators

5 December 2023 – 26 scientists have been selected to join the EMBO Young Investigator Programme, an initiative that supports excellent young group leaders in the early stages of their independent careers. Starting in January 2024, the new EMBO Young Investigators will receive a wide range of financial and practical support….

Continue Reading EMBO announces new Young Investigators

BioSenic on its way to find the necessary funds to perform

PRESS RELEASE – INSIDE INFORMATION         Biosenic signs term sheet with SPRIM Global Investments (TrialCap fund) for up to USD 8 million debt financing and USD 800,000 equity investment as a first decisive, financing step towards a Phase 3 clinical trial for its ground-breaking auto-immune medication, a first-in-class drug oral…

Continue Reading BioSenic on its way to find the necessary funds to perform

RNA- Based Therapeutic Market worth $29.41 Bn by 2031

JERSEY CITY, N.J., Dec. 5, 2023 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global RNA- Based Therapeutic Market– by Drug Class (RNA Aptamer, siRNA, Antisense RNA, mRNA), By Therapeutic Area (Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP)), Trends,…

Continue Reading RNA- Based Therapeutic Market worth $29.41 Bn by 2031

Whole Genome Amplification (WGA) Industry on Track to Surpass US$ 5.5 Billion Mark by 2033-FMI Report

Whole genome amplification industry value is anticipated to surpass US$ 5.5 Billion by the end of 2033, according to Future Market Insights (FMI) in its market analysis, as the demand for WGA in forensics and the study of genetic disorders is on the rise. Whole genome amplification sales are anticipated…

Continue Reading Whole Genome Amplification (WGA) Industry on Track to Surpass US$ 5.5 Billion Mark by 2033-FMI Report

Watch & Stream Online via Hulu

Futurama Season 2 is an animated sci-fi sitcom that follows the adventures of Philip J. Fry, a cryogenical who had been preserved for 1000 years but is brought back to life in 2999. Moreover, it was created by Matt Groening and released by Fox Broadcasting Company in November 1999. Here’s…

Continue Reading Watch & Stream Online via Hulu

DNA Sequencing Market Surges: Unraveling the Future

DNA Sequencing Market DNA Sequencing Market Report Scope: This report serves as a genetic roadmap, comprehensively examining the DNA Sequencing Market. From breakthrough technologies and market drivers to regional insights and future trends, the report sheds light on the expansive landscape of DNA sequencing. Stakeholders seeking to decipher the intricacies…

Continue Reading DNA Sequencing Market Surges: Unraveling the Future

Cell-Free DNA (cfDNA) Testing Market is Expected to Reach at a CAGR of 9.40%

New Jersey (United States) – The Cell-Free DNA (cfDNA) Testing Market research report provides all the information related to the industry. It gives the market’s outlook by giving authentic data to its client, which helps to make essential decisions. It provides an overview of the market, which includes its definition,…

Continue Reading Cell-Free DNA (cfDNA) Testing Market is Expected to Reach at a CAGR of 9.40%

Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postpr

Introduction As the prevalence of hyperlipidemia has increased, the assessment of blood lipids is increasingly important.1 At present, fasting lipid indices, including total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels are most commonly assessed in clinical practice.2 Among them, the TG level is one of the most…

Continue Reading Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postpr

Orchid Introduces Pioneering Whole Genome Sequencing Reports for Embryos After Raising $12M in Funding

Orchid, a reproductive technology company, has announced the introduction of the world’s first 30x whole genome sequencing reports for embryos. This innovation, supported by a $12M in total funding, is set to provide prospective parents with unprecedented insights into the genetic health of embryos. Orchid’s investors include Prometheus Fund, Starbloom…

Continue Reading Orchid Introduces Pioneering Whole Genome Sequencing Reports for Embryos After Raising $12M in Funding

Metagenomic Sequencing Market worth $4.5 billion in 2028

PRESS RELEASE Published December 5, 2023 “The European market is the second-largest metagenomic sequencing market globally, mainly due to factors such as increasing number of research projects, especially in the field of soil microbiome metagenomics, in the region.” Browse 226 market data Tables and 44 Figures spread through 266 Pages…

Continue Reading Metagenomic Sequencing Market worth $4.5 billion in 2028

Circulating Biomarker for Liquid Biopsy Market is growing rapidly worldwide

Statsndata has published a report on the process of collecting, analyzing and interpreting Circulating Biomarker for Liquid Biopsy Market data. It has published reports on how companies collect, analyze and interpret their market data. This helps businesses better understand the Circulating Biomarker for Liquid Biopsy Market, identify customer needs and…

Continue Reading Circulating Biomarker for Liquid Biopsy Market is growing rapidly worldwide

FDA Clears IND for CT071 in RRMM and Primary Plasma Cell Leukemia

An investigational new drug application was cleared by the FDA for CT071 in this indication. CT071 is an autologous chimeric antigen receptor (CAR) T-cell therapy candidate being developed for the treatment of multiple myeloma (MM) and primary plasma cell leukemia (PCL). A phase 1 trial evaluating CT071 is ongoing in…

Continue Reading FDA Clears IND for CT071 in RRMM and Primary Plasma Cell Leukemia

Integrative taxonomy of Metastrongylus spp. in wild boars from Brazil | Parasites & Vectors

Study areas The samples were collected from wild boars hunted in rural properties from the municipalities of São Simão, Monte Azul, Paraíso, Colina, Matão, Bebedouro e Monte Alto (São Paulo), Ipiranga (Paraná), and Santo Antônio das Missões (Rio Grande do Sul) (Fig. 1). Fig. 1 Sampling collection sites of wild boars…

Continue Reading Integrative taxonomy of Metastrongylus spp. in wild boars from Brazil | Parasites & Vectors

Now Intel Promises A 20-40% Increase And Even More, But Is This Enough To Catch Up With The AMD Monsters? A Document About The Emerald Radips Generation Xeon CPU Has Leaked Online

The successful launch of Ireland’s first satellite, EIRSAT-1, capped six years of continuous effort and work. On December 1, the small satellite, measuring just 10.7 cm x 10.7 cm x 22.7 cm, was successfully launched into orbit using a SpaceX Falcon-9 launch vehicle from the Vandenberg Space Launch Center in…

Continue Reading Now Intel Promises A 20-40% Increase And Even More, But Is This Enough To Catch Up With The AMD Monsters? A Document About The Emerald Radips Generation Xeon CPU Has Leaked Online

Alzheimer’s blood test could hit the market in early 2024, researchers say

Could a simple blood test detect Alzheimer’s disease years before symptoms appear? New research from Resonant, a Utah biotech company that develops diagnostic tests for neurodegenerative diseases, suggests it may be possible. Researchers said its new test achieved 100% accuracy in identifying patients with Alzheimer’s disease and individuals with mild cognitive impairment (MCI) who went…

Continue Reading Alzheimer’s blood test could hit the market in early 2024, researchers say

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR� assay for minimal residual disease (MRD) will be presented at the 46th annual San Antonio Breast Cancer Symposium (SABCS). RaDaR data will be…

Continue Reading NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma USA – English APAC – Traditional Chinese APAC – English

ROCKVILLE, Md. and SUZHOU, China, Dec. 5, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announced the interim analysis results of ORIENT-16, the Phase 3 study evaluating…

Continue Reading Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma USA – English APAC – Traditional Chinese APAC – English

Hot Topics in Contemporary Crystallography course (HTCC6)

Website: htcc6.org/ Workshop information: Since 2014, HTCC workshops have tackled the most fascinating achievements in both experimental methods and theoretical approaches, that have recently brought structural research to the forefront of natural sciences. We try to bring together leading experts in selected domains as lecturers, and motivated scientists in crystallography or…

Continue Reading Hot Topics in Contemporary Crystallography course (HTCC6)

Neurocrine Biosciences (NBIX) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for crinecerfont in congenital adrenal hyperplasia. The Company also provided updates on its R&D portfolio and strategy at its Analyst Day, held in New York. “We are very pleased that…

Continue Reading Neurocrine Biosciences (NBIX) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia

Urgently Require Online Bioinformatics Training in Gajularamaram, Hyderabad – Job ID 14722542

About the Job I am looking for Bioinformatics Training in and around Gajularamaram, Hyderabad. I am looking to be taught online. We are looking for someone who takes keen interest in the class. I prefer classes to be taken during the day. 100% Remote Job. Job Details Job Location Online…

Continue Reading Urgently Require Online Bioinformatics Training in Gajularamaram, Hyderabad – Job ID 14722542

Global Drug Designing Tools Industry is predicted to experience an 8.7% CAGR spanning 2023 to 2033 | FMI

Drug Designing Tools Industry The global drug designing tools industry size is anticipated to expand its roots at a steady CAGR of 8.7% between 2023 and 2033. The market is expected to have a market share of US$ 7.1 billion by 2033 while it is likely to be valued at…

Continue Reading Global Drug Designing Tools Industry is predicted to experience an 8.7% CAGR spanning 2023 to 2033 | FMI

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies Palazestrant (OP-1250) in combination with the CDK 4/6 inhibitors, ribociclib and palbociclib, demonstrated no significant drug-drug interaction, no dose-limiting toxicities and a tolerability profile consistent with the FDA-approved labels of ribociclib or palbociclib…

Continue Reading Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies

Bioinformatics Analyst in Proteomics – basel-jobs.ch

The Position In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity,…

Continue Reading Bioinformatics Analyst in Proteomics – basel-jobs.ch

Django-Ninja Unleashed: Crafting Stellar APIs | by StartxLabs Technologies | Dec, 2023

Django-Ninja Unleashed: Crafting Stellar APIs In the dynamic realm of web development, the quest for the perfect framework to build robust and efficient REST APIs has led developers to explore alternatives beyond the traditional. Enter Django-Ninja, a Python web framework tailored specifically for crafting RESTful APIs. In this comprehensive guide,…

Continue Reading Django-Ninja Unleashed: Crafting Stellar APIs | by StartxLabs Technologies | Dec, 2023

Pfizer, after delay, completes enrollment in Lyme vaccine trial

Dive Brief: Pfizer and partner Valneva announced Monday that they have finished enrolling participants in a Phase 3 trial evaluating their experimental vaccine for Lyme disease. The announcement ends a lengthy delay that began in February, when the two companies said they were removing half of trial participants due to…

Continue Reading Pfizer, after delay, completes enrollment in Lyme vaccine trial

Post Masters RA – Bioinformatics Data Scientist – Richland

**Overview** The Earth and Biological Sciences Directorate (EBSD) leads novel and necessary research in three core areas: Atmospheric and Climate sciences, Biological Sciences, and Environmental Molecular Sciences. The contributions of EBSD staff are many as we continue to elevate the impact of PNNL’s science mission: to understand, predict, and control…

Continue Reading Post Masters RA – Bioinformatics Data Scientist – Richland

Cerillion hits Platinum-level in TM Forum’s Open API conformance program

LONDON, Dec. 5, 2023 /PRNewswire/ — Cerillion (AIM: CER), a leading provider of BSS/OSS-as-a-Service solutions to the telecoms sector, announced today that it has reached Platinum-level certification for TM Forum Open APIs and is at the top of the list of vendors certified in real-world deployments. This significant achievement underscores Cerillion’s…

Continue Reading Cerillion hits Platinum-level in TM Forum’s Open API conformance program

Phase 3 trial of 64Cu-SAR-bisPSMA in prostate cancer launches

The phase 3 CLARIFY trial (NCT06056830) exploring the diagnostic performance of 64Cu-SAR-bisPSMA in patients with prostate cancer has commenced following the initiation of the first clinical trial site at the Urology Cancer Center/XCancer in Omaha, Nebraska, announced Clarity Pharmaceuticals, the developer of the theranostic, in a news release.1 The CLARIFY…

Continue Reading Phase 3 trial of 64Cu-SAR-bisPSMA in prostate cancer launches

European Firms Grappling with Generative AI Value, Set to Double Investments by 2024

Europe is doubling down on generative AI (GenAI) investment but is on a more cautious path than North America, according to new research from the Infosys Knowledge Institute (IKI), the research arm of Infosys. The research forecasts that European companies will increase GenAI investments by 115% in the next year, to $2.8 billion. The pace of…

Continue Reading European Firms Grappling with Generative AI Value, Set to Double Investments by 2024

MATLAB Documentation Center

Select a Web Site Choose a web site to get translated content where available and see local events and offers. Based on your location, we recommend that you select: . You can also select a web site from the following list: How to Get Best Site Performance Select the China…

Continue Reading MATLAB Documentation Center

Data Visualization Tools Market Research

PRESS RELEASE Published December 5, 2023 Market Overview:Data Visualization Tools market looks promising in the next 5 years. The global Data Visualization Tools market was estimated at USD 5905.05 million, and it’s anticipated to reach USD 9987.99 million in 2031, with a CAGR of 9.15% during the forecast years.Data visualization…

Continue Reading Data Visualization Tools Market Research

How has dna sequencing evolved?

How has the gene therapy evolved over the years?3 answersGene therapy has evolved significantly over the years, bringing about a revolutionary approach in disease therapy. It aims to treat the fundamental cause of disease by introducing exogenous genetic material into the body to target mutated or affected cells. Gene therapy…

Continue Reading How has dna sequencing evolved?

Frontline Nivolumab/Chemo Earns FDA Priority Review in Urothelial Carcinoma

Supporting data for the application came from the phase 3 CheckMate 901 trial (NCT03036098), which investigators presented at the 2023 European Society for Medical Oncology Congress (ESMO)and subsequently published in The New England Journal of Medicine. The FDA has granted priority review to a supplemental biologics license application for frontline…

Continue Reading Frontline Nivolumab/Chemo Earns FDA Priority Review in Urothelial Carcinoma

IBM quantum computers make sizeable leap

IBM unveiled its Condor and Heron quantum processing units Monday, which keeps the company on its own public roadmap, and by most accounts, in the lead of the quantum computing arms race. The Condor QPU, with 1,141 qubits, is the second-fastest in the world.  Heron is smaller, with 133…

Continue Reading IBM quantum computers make sizeable leap

Can breast milk analysis help diagnose early breast cancer?

How DNA sequencing of breast milk can replace tissue imaging for early diagnosis of breast cancer in pregnant and lactating women Markella Loi | 12/05/2023 | 4 min read | News Approximately 1 in 3,000 women will be diagnosed with breast cancer during pregnancy (PrBC) or postpartum period (PPBC), making…

Continue Reading Can breast milk analysis help diagnose early breast cancer?

ChatGPT gives longer responses if you ‘tip it $200,’ according to one user

Jeez, tipping has gotten so out of control, even ChatGPT expects a little something extra these days. According to programmer Theia Vogel, who goes by @voooooogel on X (formerly Twitter), ChatGPT gives longer responses if you offer to tip it. SEE ALSO: DoorDash rightfully bothers users who don’t tip A…

Continue Reading ChatGPT gives longer responses if you ‘tip it $200,’ according to one user

Merck signs $70 million deal to commercialize Abbisko’s new cancer drug in China

TGCT is a benign tumor of the joints that can cause swelling, pain, stiffness, and limited mobility of the affected joints. Treatment options for this disease, which can seriously affect patients’ quality of life, are very limited. The agreement grants Merck an exclusive license to commercialize pimicotinib in mainland China,…

Continue Reading Merck signs $70 million deal to commercialize Abbisko’s new cancer drug in China

Eels Electric Shocks Could Transfer Genes to Animals

The electric eel is the biggest power-making creature on Earth. It can release up to 860 volts, which is enough to run a machine. In a recent study, a research group from Nagoya University in Japan found electric eels can release enough electricity to genetically modify small fish larvae. They…

Continue Reading Eels Electric Shocks Could Transfer Genes to Animals

Animal Model Market Paws Its Way to Surpassing US$ 2.4 Billion by 2028-FMI Study

PRESS RELEASE Published December 5, 2023 The animal models market is expected to be worth US$ 1.7 billion in 2022 and US$ 2.4 billion by 2028, growing at a healthy CAGR of 6.6% during that period. The animal model market has witnessed substantial growth and continues to be a crucial tool…

Continue Reading Animal Model Market Paws Its Way to Surpassing US$ 2.4 Billion by 2028-FMI Study

Top 7 Generative AI Jobs in India

A year ago, OpenAI introduced its generative AI chatbot as a research prototype, and unexpectedly, it became highly sought after in 2023. The demand for generative AI is evident in the doubling of global job postings mentioning AI or generative AI on LinkedIn from July 2021 to July 2023. This…

Continue Reading Top 7 Generative AI Jobs in India

CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain…

Abstract Discovery of genomic safe harbor sites (SHSs) is fundamental for multiple transgene integrations, such as reporter genes, chimeric antigen receptors (CARs), and safety switches, which are required for safe cell products for regenerative cell therapies and immunotherapies. Here we identified and characterized potential SHS in human cells. Using the…

Continue Reading CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain…

How to read fcs3.2 files

How to read fcs3.2 files 0 @731cf19b Last seen 13 hours ago Hong Kong Hello, I have a fcs file in version 3.2. I have tried several packages in R to load it but all of them failed to work. I was wondering if there are packages that can read…

Continue Reading How to read fcs3.2 files

Faith Meets Byte: Unraveling the Holy Code of Blockchain and Scriptures | by Cindrum Official | Dec, 2023

Throughout the time, religion and science have choreographed a dance of discord, from the historic Galileo to contemporary debates on evolution and cosmic creation. This dance revolves around the perceived threat scientific discoveries pose to sacred scripts, challenging religious doctrines entrenched in the binary code of belief. In this techno-theological…

Continue Reading Faith Meets Byte: Unraveling the Holy Code of Blockchain and Scriptures | by Cindrum Official | Dec, 2023

Melinta Therapeutics & Cidara Therapeutics Announce Publication of Pooled Data from Phase 3 Pivotal ReSTORE Trial

PARSIPPANY, N.J. & SAN DIEGO–(BUSINESS WIRE)– Melinta Therapeutics, LLC and Cidara Therapeutics, Inc. (NASDAQ: CDTX) today announced the peer-reviewed publication of pooled data from two completed global clinical trials evaluating REZZAYO® (rezafungin for injection) for the treatment of candidemia and invasive candidiasis. The article, “Efficacy and safety of rezafungin and…

Continue Reading Melinta Therapeutics & Cidara Therapeutics Announce Publication of Pooled Data from Phase 3 Pivotal ReSTORE Trial

Vertex rh Latest Developer Job Openings

devjobsscanner Post a JobJobsBlog Search Search Advanced options Remote Min. Salary… Min. Date… Sort by… Vertex Fellow Oxford Vertex Pharmaceuticals Oxford, England, United Kingdom 3 weeks agofromlinkedin See offer Principal Engineer, Vertex AI Search Quality Google Sunnyvale, CA 2 weeks agofromlinkedin See offer SAP VERTEX Technical/Developer Troubleshooting Expert Denken Solutions…

Continue Reading Vertex rh Latest Developer Job Openings

Scientists Shed Light on Mysteries Associated with Infertility

BYLINE: Kitta MacPherson Newswise — Scientists attacking the problem of high miscarriage rates have long wondered if there is a way to tell whether an egg cell will successfully develop into an embryo and grow or if there is a marker indicating when it is destined to fail. Two Rutgers-led…

Continue Reading Scientists Shed Light on Mysteries Associated with Infertility

Job application portal – Webcruiter

By using this service you give Webcruiter permission to use cookies to give you a better service. OK Read more The job application service you are about to start using is owned and operated by Webcruiter AS. All information in this CV and recruitment database is stored in accordance…

Continue Reading Job application portal – Webcruiter

Vertex search Latest Developer Job Openings

devjobsscanner Post a JobJobsBlog Search Search Advanced options Remote Min. Salary… Min. Date… Sort by… Principal Engineer, Vertex AI Search Quality Google Sunnyvale, CA 2 weeks agofromlinkedin See offer Vertex Fellow Oxford Vertex Pharmaceuticals Oxford, England, United Kingdom 3 weeks agofromlinkedin See offer SAP VERTEX Technical/Developer Troubleshooting Expert Denken Solutions…

Continue Reading Vertex search Latest Developer Job Openings

Post-Doctoral Research Fellow: Bioinformatics and Metagenomic at Africa Health Research Institute (AHRI) December, 2023

Administration / SecretarialAgriculture / Agro-AlliedArt / Crafts / LanguagesAviation / AirlineBankingBuilding and ConstructionCatering / ConfectioneryConsultancyCustomer CareData, Business Analysis and AIDrivingEducation / TeachingEngineering / TechnicalExpatriateFinance / Accounting / AuditGeneralGraduate JobsHospitality / Hotel / RestaurantHuman Resources / HRICT / ComputerInsuranceInternships / VolunteeringJanitorial ServicesLaw / LegalLogisticsManufacturingMedia / Advertising / BrandingMedical / HealthcareMyJobMagNGO/Non-ProfitOil and…

Continue Reading Post-Doctoral Research Fellow: Bioinformatics and Metagenomic at Africa Health Research Institute (AHRI) December, 2023

4 Google Gemini Models Coming To The Vertex AI Model Garden

Google postponed the launch of Gemini, which was initially set for next week, reportedly due to the AI’s inconsistent performance with non-English queries. However, according to a new briefing, Google is allegedly prepping for a public preview of Gemini. This information may have been confirmed on X by Vertex AI…

Continue Reading 4 Google Gemini Models Coming To The Vertex AI Model Garden

Want Extra Monthly Cash? 1 Dividend Stock to Buy Now and Hold Forever

Image source: Getty Images Written by Amy Legate-Wolfe at The Motley Fool Canada In this market that continues to be quite volatile, it’s clear that finding a great dividend stock holds value. Yet even in any market condition, a great dividend stock is a winner to have on the books….

Continue Reading Want Extra Monthly Cash? 1 Dividend Stock to Buy Now and Hold Forever

Bold Predictions for Generative AI in 2024

As we are nearing the end of 2023, we are probably standing at the high crest of the generative AI wave. From being termed word of the year to being the crux of every major big tech company announcements this year, including Google, Microsoft, and others, it is a no-brainer…

Continue Reading Bold Predictions for Generative AI in 2024

New species of moth discovered in west London park

A lifelong moth enthusiast has discovered a new species at her local park in Ealing, west London. Barbara Mulligan caught the tiny insect in her moth trap at Walpole Park and sent it to the Natural History Museum for testing. Through DNA analysis, the museum confirmed the find was unknown…

Continue Reading New species of moth discovered in west London park

Unlocking Tomorrow: Journey into the Future of Technology | by Evanrutchik | Dec, 2023

In the ever-evolving landscape of technological innovation, the future promises a tapestry of advancements that will redefine the way we live, work, and interact. As we stand on the precipice of tomorrow, the journey into the future of technology unveils a realm of possibilities that were once confined to the…

Continue Reading Unlocking Tomorrow: Journey into the Future of Technology | by Evanrutchik | Dec, 2023

Identification and validation of key miRNAs for colon cancer

Introduction With nearly 2 million new cases and 1 million deaths worldwide in 2020, colorectal cancer is the third-most common cancer and the second leading cause of cancer-related deaths.1 According to data from the US Surveillance, Epidemiology and End Results program and the National Program of Cancer Registries program, the…

Continue Reading Identification and validation of key miRNAs for colon cancer

VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

— In the Study, VAX-24 Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20®(PCV20) at all Doses Studied — — All 24 Serotypes of VAX-24 at Conventional 2.2 mcg PCV Dose Met or Exceeded Regulatory Immunogenicity Standards — — Results Confirm Potential of Carrier-Sparing, Cell-Free Platform Technology Underlying VAX-24 — — Topline…

Continue Reading VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

Key Genes for Pyroptosis-induced Salivary Gland Inflammation

Kaiyuan Zhang,1,* Ziyue Luo,1,* Xinchao Zhu,1 Xinyi Yao,1 Dingqi Lu,2 Liying Chen,1 Tao Hong,1 Yating Ren,1 Xinchang Wang3 1Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People’s Republic of China; 2First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People’s Republic of China;…

Continue Reading Key Genes for Pyroptosis-induced Salivary Gland Inflammation

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic…

Application based on results from the Phase 3 CheckMate -901 trial showing significant survival improvement vs. standard-of-care gemcitabine plus cisplatin in cisplatin-eligible patients with untreated, unresectable or metastatic urothelial carcinoma If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the U.S. The…

Continue Reading U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic…

Molecular Dynamics Software Market Development Status 2029

[New York, November 2023] – A comprehensive market analysis report on the Molecular Dynamics Software Market has been unveiled by StatsNData and offers valuable insights and information for both industry veterans and newcomers. This in-depth report not only provides revenue forecasts for the Molecular Dynamics Software market and its sub-segments,…

Continue Reading Molecular Dynamics Software Market Development Status 2029

CTL019 Out of Specification MAP for ALL or DLBCL Patients

Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release. Stanford is currently accepting patients for this trial. Eligibility Inclusion Criteria: Patients eligible for…

Continue Reading CTL019 Out of Specification MAP for ALL or DLBCL Patients

Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer’s disease dataset

doi: 10.7554/eLife.90214. Affiliations Expand Affiliations 1 UK Dementia Research Institute at Imperial College London, London, United Kingdom. 2 Department of Brain Sciences, Imperial College London, London, United Kingdom. Item in Clipboard Alan E Murphy et al. Elife. 2023. Show details Display options Display options Format AbstractPubMedPMID doi: 10.7554/eLife.90214. Affiliations 1 UK…

Continue Reading Avoiding false discoveries in single-cell RNA-seq by revisiting the first Alzheimer’s disease dataset

How bacteria inhibit gene expression

Bacteria adapt to environmental changes by regulating their metabolism. The best way to do this is to change the gene expression. Proteins called transcription factors take care of this job and help organisms respond to change. The transcription factor CarD is conserved among several bacterial lineages and reacts with other…

Continue Reading How bacteria inhibit gene expression

Freshers Bioinformatics Jobs at Eminent Biosciences (EMBS)

–Must See– Freshers Bioinformatics Jobs at Eminent Biosciences (EMBS) Opportunities for BE / B.Tech / M.Sc / M.Tech / Bioinformatics (Only for Freshers) at Eminent Biosciences (EMBS), Indore. DBT (Govt of India) Funded project position at Eminent Biosciences (EMBS), Indore. Project Title: Personalized cancer treatment using Next-Generation Sequencing in Clinical…

Continue Reading Freshers Bioinformatics Jobs at Eminent Biosciences (EMBS)

Clinical Oncology Next Generation Sequencing Market Expected to Grow at a CAGR of 15.86% from 2023 to 2031

InsightAce Analytic Pvt. LTd. Companies covered in this report are Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, F. Hoffmann-La Roche Ltd., Myriad Genetics, Perkin Elmer, Caris Life Sciences, Partek, Inc., Eurofins Scientific, and Qiagen N.V., Foundation Medicine, Pacific Bioscience, Oxford Nanopore Technologies Ltd., Paradigm Diagnostics, Beijing Genomics Institute (BGI), Takara…

Continue Reading Clinical Oncology Next Generation Sequencing Market Expected to Grow at a CAGR of 15.86% from 2023 to 2031

Bioinformatics Jobs at Kokilaben Dhirubhai Ambani Hospital

–Must See– Bioinformatics Jobs at Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute Technical Executive / Senior Technical Executive – Bioinformatics Job No.: TECH 02 Department: Medical Staff Location: Mumbai Work Experience: 3 – 7 Years Qualification: BSc / MSc / PhD / 10+ years’ experience in Biological Science Description:…

Continue Reading Bioinformatics Jobs at Kokilaben Dhirubhai Ambani Hospital

Vertex Latest Developer Job Openings

devjobsscanner Post a JobJobsBlog Search Search Advanced options Remote Min. Salary… Min. Date… Sort by… Vertex Fellow Oxford Vertex Pharmaceuticals Oxford, England, United Kingdom 3 weeks agofromlinkedin See offer Principal Engineer, Vertex AI Search Quality Google Sunnyvale, CA 2 weeks agofromlinkedin See offer SAP VERTEX Technical/Developer Troubleshooting Expert Denken Solutions…

Continue Reading Vertex Latest Developer Job Openings

Vertex compliance Latest Developer Job Openings

devjobsscanner Post a JobJobsBlog Search Search Advanced options Remote Min. Salary… Min. Date… Sort by… Vertex Fellow Oxford Vertex Pharmaceuticals Oxford, England, United Kingdom 3 weeks agofromlinkedin See offer Principal Engineer, Vertex AI Search Quality Google Sunnyvale, CA 2 weeks agofromlinkedin See offer SAP VERTEX Technical/Developer Troubleshooting Expert Denken Solutions…

Continue Reading Vertex compliance Latest Developer Job Openings

Lablab.ai’s TruEra Challenge with Google Cloud Vertex AI and TruLens

Delaware, United States, Dec. 05, 2023 (GLOBE NEWSWIRE) —  lablab.ai, an initiative by New Native, proudly announces the TruEra Challenge, slated to commence on Friday, December 1, 2023, at 6:00 PM CET. This hackathon isn’t just a competition; it’s a bold endeavor to redefine AI possibilities, powered by the convergence…

Continue Reading Lablab.ai’s TruEra Challenge with Google Cloud Vertex AI and TruLens

Comparative genomics and proteomics analysis of phages infecting multi-drug resistant Escherichia coli O177 isolated from cattle faeces

Batinovic, S. et al. Bacteriophages in natural and artificial environments. Pathogens 8, 100. doi.org/10.3390/pathogens8030100 (2019). Article  PubMed  PubMed Central  Google Scholar  Mushegian, A. R. Are there 10^31 virus particles on earth, or more, or fewer?. J. Bacteriol. 202(9), 2020. doi.org/10.1128/JB.00052-20 (2020). Article  Google Scholar  Kutter, E. & Sulakvelidze, A. Bacteriophages:…

Continue Reading Comparative genomics and proteomics analysis of phages infecting multi-drug resistant Escherichia coli O177 isolated from cattle faeces

Research Assistant Full time jobs in France | Fixed term

Broaden your search Refine your search Sign up for job alerts Get new jobs for this search by email Found 2 Fixed term jobs About the team/job The European Molecular Biology Laboratory (EMBL) is a…

Continue Reading Research Assistant Full time jobs in France | Fixed term

Operations Manager – Data Science Centre at European Molecular Biology

About the team/job:EMBL is a leading life sciences laboratory in Europe, comprised of over 110 independent research groups and service teams focused on molecular biology. It operates across six sites and is dedicated to performing basic research, providing training and services, developing new methods, and actively engaging in technology transfer….

Continue Reading Operations Manager – Data Science Centre at European Molecular Biology

Microbial gene expression analysis of healthy and cancerous esophagus uncovers bacterial biomarkers of clinical outcomes

Yang J, Liu X, Cao S, Dong X, Rao S, Cai K. Understanding esophageal cancer: the challenges and opportunities for the next decade. Front Oncol. 2020;10:1727. Article  PubMed  PubMed Central  Google Scholar  Li J, Xu J, Zheng Y, Gao Y, He S, Li H, et al. Esophageal cancer: epidemiology, risk…

Continue Reading Microbial gene expression analysis of healthy and cancerous esophagus uncovers bacterial biomarkers of clinical outcomes

Android C++ Developer- Local Candidates Only – HYR Global Source Inc

Position:Android C++ Developer– Local Candidates Only Location:Burlingame, CA- Hybrid- twice a week onsite Length: 2 Years Job Type: C2C Ok, W2 preferred– (Any Visa is fine) Tech stack –Embedded Engineer-Android Embedded Systems Engineer (C/C++) Our client is looking for an Android Embedded Systems Engineer to bring onto theteam!This candidate must…

Continue Reading Android C++ Developer- Local Candidates Only – HYR Global Source Inc

FDA Shuts Down Enquiries About DNA Contamination In COVID Vaccines

Authored by Maryanne Demasi via The Brownstone Institute, The recent findings of DNA fragments in the Pfizer and Moderna Covid-19 vaccines has led many to question why the FDA, which is responsible for monitoring the quality and safety of the vaccines, has failed to sound the alarm. For years, the FDA has…

Continue Reading FDA Shuts Down Enquiries About DNA Contamination In COVID Vaccines

Needle-free ultrasound vaccine delivery | ScienceDaily

An estimated quarter of adults and two-thirds of children have strong fears around needles, according to the U.S. Centers for Disease Control and Prevention. Yet, public health depends on people being willing to receive vaccines, which are often administered by a jab. Darcy Dunn-Lawless, a doctoral student at the University…

Continue Reading Needle-free ultrasound vaccine delivery | ScienceDaily

Next Generation Sequencing Market Size & Share Report, 2032

The global Next Generation Sequencing market was valued at USD 8.26 Billion in 2022 and growing at a CAGR of 19.24% from 2023 to 2032. The market is expected to reach USD 48.01 Billion by 2032. The next-generation sequencing technologies (NGS) market has grown significantly since it was first commercialized….

Continue Reading Next Generation Sequencing Market Size & Share Report, 2032

Electroporation Instruments Market is Estimated to Witness High Growth Owing to Increasing Demand

The Electroporation Instruments Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Electroporation instruments are lab equipment used for transfection of cells through application of brief electrical pulses. They are widely utilized in biological research and…

Continue Reading Electroporation Instruments Market is Estimated to Witness High Growth Owing to Increasing Demand

How does Deseq2 deal with the row with zero when calculating size factors

How does Deseq2 deal with the row with zero when calculating size factors 0 @7dbff853 Last seen 1 hour ago United States Hi, I am confused about the calculation of the size factors when the gene has at least one zero count in the samples when using the default params….

Continue Reading How does Deseq2 deal with the row with zero when calculating size factors

Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery

CancerNetwork® spoke with Govindarajan Narayanan, MD about his practice becoming the first in the United States to successfully surgically treat a patient with a liver tumor using the Epione robot, as well as the process of transitioning from CT-based image guidance to the robotic workstation in his care.1 Narayanan, a…

Continue Reading Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery

Plasmid Dna Manufacturing Market – Market Dynamics and Forecast From 2023-2030

PRESS RELEASE Published December 4, 2023 The well-researched report on the Plasmid Dna Manufacturing market focuses on the current market trends and recent developments to help the operating players and marketing executives to plan strategies for growth for the forecast period 2023 – 2030. The report discusses major driving factors,…

Continue Reading Plasmid Dna Manufacturing Market – Market Dynamics and Forecast From 2023-2030

Next Generation Sequencers Market Growth Research Report [2024-2031]

PRESS RELEASE Published December 5, 2023 “Next Generation Sequencers Market” Research Report Provides Detailed Historical Analysis of Global market for Next Generation Sequencers from 2017 2022, and provides Extensive Market Forecasts From 2024 2031 By Applications (Diagnostics, Drug Discovery, Biomarker Discovery, Others),Types (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-Molecule…

Continue Reading Next Generation Sequencers Market Growth Research Report [2024-2031]

Pfizer, Valneva Finish Phase 3 Trial Recruitment for Lyme Vaccine

9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and Europe in 2026 New York, NY, and Saint-Herblain (France), December 4, 2023 – Pfizer Inc. (NYSE:…

Continue Reading Pfizer, Valneva Finish Phase 3 Trial Recruitment for Lyme Vaccine

Integrating extracellular vesicle and circulating cell-free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients

doi: 10.1002/jex2.108. Epub 2023 Sep 25. Vera Mugoni  1 , Yari Ciani  1 , Orsetta Quaini  1 , Simone Tomasini  1 , Michela Notarangelo  1 , Federico Vannuccini  1 , Alessia Marinelli  1 , Elena Leonardi  2 , Stefano Pontalti  3 , Angela Martinelli  1 , Daniele Rossetto  1 , Isabella Pesce  1 , Sheref S Mansy  1 , Mattia Barbareschi  2 , Antonella…

Continue Reading Integrating extracellular vesicle and circulating cell-free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients

Early Screening Crucial to Manage Rare Genetic Disorders, Health News, ET HealthWorld

by Dr Mayank Nilay Rare genetic disorders, often referred to as orphan diseases, are conditions that affect a small percentage of the population. These disorders, while individually rare, collectively impact millions of people worldwide. Early diagnosis and intervention are crucial for managing these conditions effectively. Over the years, significant advancements…

Continue Reading Early Screening Crucial to Manage Rare Genetic Disorders, Health News, ET HealthWorld

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Cell line and growth assays Cell lines were grown in Roswell Park Memorial Institute-1640 medium (RPMI-1640) with 1% penicillin–streptomycin (10,000 U ml−1) and 10% FBS or in Iscove’s modified Dulbecco’s medium (IMDM) with 1% penicillin–streptomycin (10,000 U ml−1), l-glutamine (200 mM) and 10% FBS in a humidified incubator with 5% CO2 maintained at 37 °C. Drugs…

Continue Reading The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and…

Continue Reading Pfizer and Valneva Complete Recruitment for Phase 3 VALOR

AI Training Dataset Market analysis until 2029

[Manhattan, New York – Dec 2023] — A ground-breaking market research report on the AI Training Dataset Market has been published by STATS N DATA, which aims to provide investors and organizations with a comprehensive overview of the global AI Training Dataset market. This comprehensive report goes beyond data –…

Continue Reading AI Training Dataset Market analysis until 2029

the future of disease treatment

Like many people I know, I am badly undereducated in biology. Whatever I was taught in high school was instantly forgotten when I left, and I never got near it again. Except that it is in our faces daily — diet, health, diseases, cures — we are all bouncing against…

Continue Reading the future of disease treatment

Congressmen, industry leaders call on EPA to finalize emissions rule

© Shutterstock On Wednesday, U.S. Sens. Alex Padilla (D-CA) and Sheldon Whitehouse (D-RI) joined leaders from the heavy-duty vehicle industry to urge the Environmental Protection Agency (EPA) to finalize emission rules. The Senators, along with Matt LeDucq, CEO of Forum Mobility; Nikolas Runge, CTO of InCharge; Nate Baguio, senior vice…

Continue Reading Congressmen, industry leaders call on EPA to finalize emissions rule

Scientists Unravel Infertility Mysteries | Mirage News

Two Rutgers-led studies point to answers on egg cell success and failure Scientists attacking the problem of high miscarriage rates have long wondered if there is a way to tell whether an egg cell will successfully develop into an embryo and grow or if there is a marker indicating when…

Continue Reading Scientists Unravel Infertility Mysteries | Mirage News

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15

9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and Europe in 2026 New York, NY, and Saint-Herblain (France), December 4, 2023 – Pfizer Inc. (NYSE:…

Continue Reading Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15

NOTCH1 mutations predict superior outcomes, NSCLC

Introduction Lung cancer remains the leading cause of cancer-related mortality worldwide, and the majority are non-small-cell lung cancer (NSCLC).1,2 Genetic variation is a typical feature of NSCLC that drives cancer initiation and progression.3 Understanding the role of mutated genes in NSCLC is the basis of the development of novel treatment…

Continue Reading NOTCH1 mutations predict superior outcomes, NSCLC